In fact, there appear to be distinct roles for p300 in mouse models of myeloid malignancies: an oncogenic role in AML1-ETO-driven AML33 and a tumor suppressor role in MDS driven by the NUP98-HOXD13 (NHD13) fusion protein36. This evidence concerns the gene RUNX1 and myelodysplastic syndrome.